Medical Necessity Criteria for Hemoglobin A1c Testing
Hemoglobin A1c testing is medically necessary for screening, diagnosing, and monitoring diabetes in adults with overweight/obesity plus one or more risk factors, or in all adults starting at age 35 years, with repeat testing at minimum 3-year intervals if normal. 1
Screening Indications
Adults Who Should Be Tested
HbA1c testing is appropriate for:
Adults with overweight or obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian ancestry) who have at least one of the following risk factors 1:
- First-degree relative with diabetes
- High-risk race/ethnicity (African American, Latino, Native American, Asian American)
- History of cardiovascular disease
- Hypertension (≥130/80 mmHg or on therapy)
- HDL cholesterol <35 mg/dL or triglycerides >250 mg/dL
- Polycystic ovary syndrome
- Physical inactivity
- Conditions associated with insulin resistance (severe obesity, acanthosis nigricans, metabolic dysfunction-associated steatotic liver disease)
All adults starting at age 35 years, regardless of weight or risk factors 1
People with prediabetes (A1c ≥5.7% [≥39 mmol/mol]) should be tested yearly 1
Women with prior gestational diabetes should have testing at least every 1-3 years 1
Youth Screening Criteria
Testing should be considered after puberty onset or age 10 years (whichever comes first) in youth with overweight (≥85th percentile) or obesity (≥95th percentile) plus additional risk factors including maternal diabetes/gestational diabetes, family history, high-risk ethnicity, or signs of insulin resistance 1.
Diagnostic Thresholds
For diagnosis of diabetes: HbA1c ≥6.5% (≥48 mmol/mol), confirmed with repeat testing in asymptomatic individuals 1
For prediabetes: HbA1c 5.7-6.4% (39-47 mmol/mol) 1
For normal glucose tolerance: HbA1c <5.7% (<39 mmol/mol) 1
Repeat Testing Intervals
If results are normal: Repeat at minimum 3-year intervals, with consideration for more frequent testing based on initial results, symptoms, or change in risk status (e.g., weight gain) 1
If prediabetes is identified: Annual testing 1
Critical Caveats: When NOT to Use HbA1c
HbA1c should NOT be used for diagnosis in conditions that alter the relationship between HbA1c and glycemia 1. Use plasma glucose criteria instead in:
- Hemoglobin variants (e.g., thalassemia)
- Pregnancy (second and third trimesters and postpartum period)
- Glucose-6-phosphate dehydrogenase deficiency
- HIV infection
- Hemodialysis or renal failure
- Recent blood loss or transfusion
- Hemolysis
- Erythropoietin therapy
- Severe anemia or altered erythrocyte turnover 1, 2
These conditions affect erythrocyte lifespan or hemoglobin structure, making HbA1c an unreliable measure of glycemic control 2, 3.
Testing Requirements
The HbA1c test must be performed using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized to the Diabetes Control and Complications Trial (DCCT) reference assay 1.
Point-of-care A1C testing for diagnosis should be restricted to FDA-approved devices at CLIA-certified laboratories performing moderate complexity testing or higher by trained personnel 1.
Advantages of HbA1c Testing
- No fasting required, allowing greater scheduling flexibility 1
- Greater preanalytic stability compared to glucose measurements 1
- Less affected by acute factors such as recent food intake, stress, illness, or activity 1
- Lower within-person variability than glucose measurements 1
- Reflects average glycemia over approximately 2-3 months 1, 2
When to Suspect Spurious Results
If there is consistent and substantial discordance between blood glucose values and HbA1c results, evaluate for test interference or conditions affecting erythrocyte turnover 1, 2. In such cases, confirm with plasma glucose measurements.